Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Iraqi hemophilia patients under the microscope: new study tracks Real-World use of clotting drug

NCT ID NCT06574984

First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 19 times

Summary

This study will look back at medical records of 900 male hemophilia A patients in Iraq to see how doctors use the clotting medicine turoctocog alfa in everyday practice. The goal is to understand how often patients have bleeding episodes while on this treatment. No new treatments or changes to care are involved—only existing data is collected.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HAEMOPHILIA A are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Basrah Haemoplhilia centre

    NOT_YET_RECRUITING

    Basra, 61001, Iraq

  • Hilla Haemophilia centre

    ENROLLING_BY_INVITATION

    Hillah, 51001, Iraq

  • Karbala Haemophilia centre

    ENROLLING_BY_INVITATION

    Karbala, 56001, Iraq

  • Kirkuk Centre for Cancer and Blood Disorders

    ENROLLING_BY_INVITATION

    Kirkuk, 36001, Iraq

  • Najaf Haemophilia Centre

    ENROLLING_BY_INVITATION

    Najaf, 54001, Iraq

  • National centre for Hamophilia

    ENROLLING_BY_INVITATION

    Baghdad, 10001, Iraq

  • Novo Nordisk Investigational Site

    RECRUITING

    Baghdad, Iraq

Conditions

Explore the condition pages connected to this study.